Addex Therapeutics Ltd
ADXN
$9.00
$0.19172.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.64M | -1.37M | -1.77M | 14.24M | -3.53M |
| Total Depreciation and Amortization | 2.40K | 27.10K | 61.90K | 124.30K | 3.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 989.40K | 819.90K | 1.09M | -14.80M | 374.00K |
| Change in Net Operating Assets | -19.40K | 499.20K | 152.30K | -2.61M | 643.80K |
| Cash from Operations | -666.00K | -26.80K | -460.80K | -3.05M | -2.51M |
| Capital Expenditure | -- | 0.00 | -1.50K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -18.10K | -5.30K | 5.16M | -- |
| Cash from Investing | -- | -18.10K | -6.80K | 5.16M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.80K | -1.80K | -2.20K | -3.00K | -66.70K |
| Issuance of Common Stock | 300.00 | 1.60K | 2.20K | 400.00 | 236.80K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -21.20K | -4.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.50K | -1.50K | -500.00 | -33.60K | -1.00K |
| Cash from Financing | 109.00K | -2.00K | -600.00 | -63.50K | 188.20K |
| Foreign Exchange rate Adjustments | -17.30K | 38.40K | -38.90K | 1.80K | 112.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 338.20K | -349.80K |
| Net Change in Cash | -574.30K | -8.50K | -507.10K | 2.39M | -2.56M |